<DOC>
	<DOCNO>NCT00545675</DOCNO>
	<brief_summary>To demonstrate difference Abilify Depakote v . Placebo Depakote 24-week treatment patient remission status Abilify Depakote 6-week study acute mania patient bipolar disorder</brief_summary>
	<brief_title>Abilify Bipolar Disorder 24 Weeks Treatment Effectiveness</brief_title>
	<detailed_description>Further study detail provide Korea OIAA</detailed_description>
	<mesh_term>Disease</mesh_term>
	<mesh_term>Bipolar Disorder</mesh_term>
	<mesh_term>Valproic Acid</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<criteria>1 . Mania mixed episode bipolar disorder accord DSMIV 2 . Male female age 18 65 ( In case childbearing woman , negative pregnancy test result confirm administration investigational drug appropriate contraception use . Pregnant breastfeed woman include ) 3 . Patients consent participate clinical trial 4 . Patients understand trial comply protocol requirement 5 . Patients fulfill follow remission criterion bipolar disorder two consecutive evaluation perform every week Week 6 6week study thereafter : ( Definition remission : score le 12 YMRS total score simultaneously score less 13 MADRS total score ) 1 . Patients follow clinical symptom diagnose use DSM1 . Patients follow clinical symptom diagnose use DSMIV : Delirium , dementia , amnestic cognitive disorder Schizophrenia schizoaffective disorder 2 . Patients respond clozapine 3 . Patients expect require administration prohibit concomitant drug clinical trial period 4 . Patients diagnose substancerelated disorder accord DSMIV within past 3 month ( abuse , intoxication , dependency and/or withdrawal symptom ) . The abuse benzodiazepine include exception caffeine nicotine . 5 . Patients know allergy hypersensitivity reaction Abilify ( aripiprazole ) quinolinones 6 . Patients high risk suicide attempt history murder mental status test 7 . Patients history neuroleptic malignant syndrome 8 . Patients past history may cause serious adverse event affect safety efficacy evaluation clinical trial period 9 . Patients clinically significantly abnormal laboratory result , vital sign ECG result 10 . Pregnant woman childbearing woman use appropriate contraception 11 . Patients history convulsive disorder 12 . Patients judge decreased compliance investigational drug 6week trial period investigator 13 . Patients commit serious protocol violation 6week trial</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>December 2009</verification_date>
</DOC>